117 related articles for article (PubMed ID: 5235146)
1. Ion-dependent activation of dihydrofolate reductase from L1210 cells.
Reyes P; Huennekens FM
Biochemistry; 1967 Nov; 6(11):3519-27. PubMed ID: 5235146
[No Abstract] [Full Text] [Related]
2. Dihydrofolate reductase from the L1210 R murine lymphoma. Further studies on the binding of substrates and inhibitors to the enzyme.
Hillcoat BL; Perkins JP; Bertino JR
J Biol Chem; 1967 Oct; 242(20):4777-81. PubMed ID: 4383525
[No Abstract] [Full Text] [Related]
3. Kinetic investigation of the reaction mechanism of dihydrofolate reductase from L1210 cells.
McCullough JL; Nixon PF; Bertino JR
Ann N Y Acad Sci; 1971 Nov; 186():131-42. PubMed ID: 4399849
[No Abstract] [Full Text] [Related]
4. Dihydrofolate reductase from mouse liver and spleen. Purification, properties and inhibition by substituted 2,4-diaminopyrimidines and 4,6-diaminotriazines.
McCullough JL; Bertino JR
Biochem Pharmacol; 1971 Mar; 20(3):561-74. PubMed ID: 4402459
[No Abstract] [Full Text] [Related]
5. Amethopterin-induced changes in the multiple forms of dihydrofolate reductase from L1210 cells.
Harding NG; Martelli MF; Huennekens FM
Arch Biochem Biophys; 1970 Mar; 137(1):295-6. PubMed ID: 5435066
[No Abstract] [Full Text] [Related]
6. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
[No Abstract] [Full Text] [Related]
7. Improved purification of tetrahydrofolate dehydrogenase from L1210 leukemia by affinity chromatography.
Chello PL; Cashmore AR; Jacobs SA; Bertino JR
Biochim Biophys Acta; 1972 Apr; 268(1):30-4. PubMed ID: 5018279
[No Abstract] [Full Text] [Related]
8. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
[No Abstract] [Full Text] [Related]
9. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
[No Abstract] [Full Text] [Related]
10. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
Jackson RC; Niethammer D; Hart LI
Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
[No Abstract] [Full Text] [Related]
11. Purification of tetrahydrofolate dehydrogenase by affinity chromatography.
Gauldie J; Hillcoat BL
Biochim Biophys Acta; 1972 Apr; 268(1):35-40. PubMed ID: 4401610
[No Abstract] [Full Text] [Related]
12. Inactivation of dihydrofolate reductase in vitro by binding to microsomal membranes.
Fox JE; Hillcoat BL
Biochem Biophys Res Commun; 1976 Dec; 73(3):562-8. PubMed ID: 1034478
[No Abstract] [Full Text] [Related]
13. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
[No Abstract] [Full Text] [Related]
14. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
Hillcoat BL; Marshall L; Gauldie J; Hiebert M
Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
[No Abstract] [Full Text] [Related]
16. Folate antagonists covalently linked to carbohydrates: synthesis, properties, and use in the purification of dihydrofolate reductases.
Whiteley JM; Jackson RC; Mell GP; Drais JH; Huennekens FM
Arch Biochem Biophys; 1972 May; 150(1):15-22. PubMed ID: 4623864
[No Abstract] [Full Text] [Related]
17. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
FitzGerald GB; Wick MM
Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
[TBL] [Abstract][Full Text] [Related]
18. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
Duffy TH; Sato JK; Vitols KS; Huennekens FM
Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
[TBL] [Abstract][Full Text] [Related]
19. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
Hillcoat BL
J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
[No Abstract] [Full Text] [Related]
20. A DIRECT ASSAY FOR DIHYDROFOLATE REDUCTASE IN HUMAN LEUKOCYTES.
MISRA DK
Blood; 1964 May; 23():572-80. PubMed ID: 14142499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
